About Dropworks
Dropworks is a Healthcare company based in Phoenix (United States) founded in 2016, and was acquired by Bio Rad in October 2021. Digital PCR instruments are manufactured for laboratory use. Its chief executive, as recorded, is Chris Perkins. Dropworks offers products and services including Digital PCR Instrument and Digital PCR Technology. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Instrument Systems. Its competitors include DermTech, NeuMoDx and GenMark Diagnostics; 3 of its 3 listed competitors have raised funding.
Company details
DropWorks was founded in 2016 and is based in Phoenix, United States. Operations focus on the biotechnology sector, where digital PCR instruments are produced for laboratory settings. Instrumentation and analytical techniques based on continuous flow droplet nanoreactors are under development. Absolute quantification and high sensitivity are enabled by the digital PCR approach. Automation of assay mixing and related innovations are being pursued.
- Headquarters Phoenix, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dropworks.com
- Social LinkedIn
- Acquired by Bio Rad (Oct 2021)
Products & Services of Dropworks
Dropworks offers a comprehensive portfolio of products and services, including Digital PCR Instrument and Digital PCR Technology.
Enables absolute quantification of nucleic acids with simple, rapid workflow.
Provides multiplexed quantification without technical replicates for research.
Investors in Dropworks
Dropworks has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bio Rad.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Portfolio of products and services for life science research and clinical diagnostic markets | 1952 | bio-rad.com | Hercules, United States |
Investor details for Dropworks
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dropworks
1 people are tracked at Dropworks (1 in leadership).
| Name | Role | Group |
|---|---|---|
Chris Perkins | CEO | Leadership |
Complete people profiles for Dropworks
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dropworks
2 dated milestones of Dropworks across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Dropworks is founded.
- Exit Acquired by Bio Rad.
Competitors of Dropworks
Dropworks has 3 listed competitors in our database, 3 of them funded. They include DermTech, NeuMoDx and GenMark Diagnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dermtech.com | 1996 | San Diego, United States | $24.37M | 259 | Adhesive patch biopsies for skin cancer detection are provided. | |
| neumodx.com | 2012 | Ann Arbor, United States | $66.04M | 125 | Developer of a platform for low cost molecular testing | |
| genmarkdx.com | 1993 | San Diego, United States | $8.56M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. |
Detailed competitors of Dropworks
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Dropworks (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dropworks
Complete news archive for Dropworks
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dropworks
Dropworks was founded in 2016.
Dropworks is headquartered in Phoenix, United States. It is registered at Phoenix, Arizona, United States.
Chris Perkins is the CEO of Dropworks, as recorded in our data.
DropWorks was founded in 2016 and is based in Phoenix, United States. Operations focus on the biotechnology sector, where digital PCR instruments are produced for laboratory settings. Instrumentation and analytical techniques based on continuous flow droplet nanoreactors are under development. Absolute quantification and high sensitivity are enabled by the digital PCR approach. Automation of assay mixing and related innovations are being pursued.
Dropworks's top competitors include DermTech, GenMark Diagnostics and NeuMoDx.
Dropworks offers Digital PCR Instrument and Digital PCR Technology.
Dropworks has 1 investor. Key investors include Bio Rad.
Yes. Dropworks was acquired by Bio Rad in October 2021.